Pharmacogenomics: A Path to Precision Stroke and Cardiac Care
Title: Pharmacogenomics: A Path to Precision Stroke and Cardiac Care
Date: October 07, 2025
Time: 01:00 PM ET
Presenters: Max Smith - PharmD, BCPS and Amanda Hanson - BS, MS, ASCP(MB)CM, CGMBS
Pharmacogenomics: A Path to Precision Stroke and Cardiac Care
The Vital Role of Pharmacogenomics in Precision Care
Pharmacogenomics is playing an increasingly vital role in cardiology and neurology, particularly in guiding antiplatelet therapy for patients at risk of further complications from minor strokes or other cerebrovascular events. This webinar will explore the latest clinical evidence supporting the use of rapid CYP2C19-guided antiplatelet therapy.
The session will highlight the practical aspects of implementing rapid CYP2C19 genotyping in clinical practice. Presenters will share lessons learned from real-world adoption, focusing on workflow integration, clinical decision support, and the role of interdisciplinary collaboration in ensuring effective use of genetic information for neurologic patients.
In addition, the webinar will address the broader infrastructure needed to support rapid genomic testing in lab and clinical environments. Topics will include best practices for lab stewardship, integrating genomic workflows, and leveraging electronic medical records (EMRs) to surface actionable insights. Attendees will leave with strategies to incorporate genomic data into clinical care pathways, supporting more precise, data-driven decisions for prevention and treatment.
Learning Objectives
This webinar will help you:
- Evaluate current clinical evidence supporting CYP2C19-guided antiplatelet therapy and its impact on patient outcomes
- Examine the implementation and clinical use of rapid CYP2C19 genotyping at MedStar Health to guide personalized antiplatelet therapy
- Interpret key considerations for implementing genomic testing in the lab, including best practices for lab stewardship and integration into existing workflows
- Discover how to leverage your EMR to surface and act on genomic insights, supporting clinical decision-making and enhancing patient care
For research use only. Not for diagnostic procedures.
Fisher Healthcare is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.™ Program. One P.A.C.E.™ credit-hour will be provided for this complimentary basic level program.
Presenters
Max Smith
PharmD, BCPS
Dr. Max Smith is a clinical pharmacogenomics specialist at MedStar Health and an assistant professor at Georgetown University Medical Center. Dr. Smith earned a PharmD at the University of Toledo and is a board-certified pharmacotherapy specialist.
Amanda Hanson
BS, MS, ASCP(MB)CM, CGMBS
Amanda Hanson is a dedicated healthcare director with over a decade of experience in clinical laboratory management, and a unique blend of expertise in precision medicine and community health. Throughout her career, Ms. Hanson has developed and implemented innovative solutions that enhance patient care and operational efficiency.